Chinese Journal of Pharmacovigilance ›› 2010, Vol. 7 ›› Issue (4): 254-254.

Received:2016-02-19 Revised:2016-02-19 Online:2010-04-08 Published:2016-02-19

Abstract

CLC Number:

R944.11

Add to citation manager EndNote|Ris|BibTeX

URL: https://zgywjj.magtechjournal.com/EN/

https://zgywjj.magtechjournal.com/EN/Y2010/V7/I4/254

[1]	YU Jing, PALATI Reheman, ZHAO Ting, FENG Jirong, SUN Yan, HE Lei. Correlation of the efficacy, safety and plasma concentration of lacosamide in the treatment of children with epilepsy under 4 years of age [J]. Chinese Journal of Pharmacovigilance, 2024, 21(5): 559-562.
[2]	CHEN Tianyu, CHEN Qiying, ZHANG Yuezhen. Adverse reactions of solriamfetol after listing based on real world data [J]. Chinese Journal of Pharmacovigilance, 2022, 19(4): 432-435.
[3]	ZHANG Dan, LYU Jintao, ZHANG Bing, LIN Zhijian, WU Huanzhang, ZHANG Xiaomeng. Construction and Application of Four-Dimensional and Chained Research Platform for Pharmacovigilance of Traditional Chinese Medicine [J]. Chinese Journal of Pharmacovigilance, 2021, 18(5): 416-421.
[4]	SA Rina, ZHANG Bing, LIN Zhijian, WANG Xiaofang, ZHANG Xiaomeng. Pharmacovigilance of Traditional Chinese Medicine in Pharmaceutical Care in Medical Institutions [J]. Chinese Journal of Pharmacovigilance, 2021, 18(5): 422-426.
[5]	ZHOU Xiangzhen, LI Jingtai, REN Shaolin, ZHANG Chunping, ZHANG Tianhua. One Case of Severe Skin Damage Induced by Combination of Doxorubicin Hydrochloride Liposome Injection and Paclitaxel for Injection (albumin-binding) [J]. Chinese Journal of Pharmacovigilance, 2021, 18(3): 280-283.
[6]	ZHANG Yongna, ZHANG Yanjiao, ZHAO Li, HAN Yongxin. One Case of Drug Treatment and Pharmaceutical Care in Patients with HIT after Coronary Artery Bypass Grafting [J]. Chinese Journal of Pharmacovigilance, 2021, 18(3): 284-288.
[7]	BIE Zhi-xin, DING Li. Clinical Characteristics of Patients with Interstitial Lung Disease Induced by Gefitinib and Erlotinib [J]. Chinese Journal of Pharmacovigilance, 2017, 14(5): 309-312.
[8]	. [J]. Chinese Journal of Pharmacovigilance, 2016, 13(1): 55-56.
[9]	YU Da-Hai, CHENG Mei, LI Bei. Analysis of 32 Cases of Adverse Drug Reaction Caused by Cervus and Cucumis Polypeptide Injection [J]. Chinese Journal of Pharmacovigilance, 2011, 8(6): 373-375.
[10]	SONG Jun, ZHAO Jun-ning ,WU Cheng-yun ,ZHOU Ya-li. Non-Clinical Safety Study's Role on Safety Reassessment of Post-Marketing Traditional Chinese Medicine [J]. Chinese Journal of Pharmacovigilance, 2010, 7(12): 730-732.
[11]	LI Ying-ran, PAN Tai-xian . Analysis of 170 Cases on Adverse Drug Reaction of Shenmai Injection [J]. Chinese Journal of Pharmacovigilance, 2010, 7(10): 623-625.
[12]	LI Ying-ran, PAN Tai-xian . Analysis of 170 Cases on Adverse Drug Reaction of Shenmai Injection [J]. Chinese Journal of Pharmacovigilance, 0, (): 623-625.
[13]	JIANG La-mei. Analysis on 161 New or Serious Reports of Xixinnao Injection [J]. Chinese Journal of Pharmacovigilance, 2010, 7(8): 500-503.
[14]	LI Zuo-fa, ZHANG Wen-dong, ZHANG Xiu-mei. Analysis on 97 Adverse Drug Reaction of Yinzhihuang injection [J]. Chinese Journal of Pharmacovigilance, 2010, 7(7): 442-443.

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 14

Recommended Articles

Metrics